Biotech stocks came under pressure, Genscript Biotech (01548) fell 9.7%, closing at HK$38.06, marking its second consecutive day of decline with a cumulative drop of 10.2%; Insilico Medicine (03696) dropped 3.8%, closing at HK$45.54, marking its second consecutive day of decline with a cumulative drop of 7.1%; WuXi Biologics (02269) declined 2.5%, closing at HK$51.35, marking its fifth consecutive day of decline with a cumulative drop of 11.3%; Kelun-Biotech (06990) fell 1.3%, closing at HK$444.

　　Middle East tensions continue to escalate, with Saudi Arabia suffering attacks by Yemen's Houthi militants for two consecutive days over the weekend, resulting in civilian casualties. Added to earlier uncertainties surrounding the Russia-Ukraine energy ceasefire, with Ukraine accusing Russia of violating the truce, the ongoing conflict has driven oil prices higher again. Currently, Brent crude futures have risen to $105.72 per barrel.

　　The biotech index is currently down approximately 2.24%, at 15,256 points, marking its fifth consecutive trading day of decline, with a cumulative drop of about 9.4% over the five days. The Hang Seng Index stands at 24,202, down 68 points or 0.3%, with main board turnover reaching nearly HK$5.4 billion. The Hang Seng China Enterprises Index is at 8,146, down 22 points or 0.3%. The Hang Seng Tech Index is at 4,128, down 40 points or 1%. (am)
 

Performance of related stocks in the same sector

Stock (Code)	Current Price (HK$)	Change (%)
Genscript Biotech (01548)	38.06	Down 9.68%
Insilico Medicine (03696)	45.54	Down 3.76%
WuXi Biologics (02269)	51.35	Down 2.47%
Kelun-Biotech (06990)	444	Down 1.29%
WuXi XDC (02268)	81.55	Down 2.63%
Innovent Biologics (01801)	90.05	Down 2.23%
ACEA Biosciences (09926)	104.4	Down 2.61%
WuXi AppTec (02359)	202.8	Down 2.41%
BeiGene (06160)	209.2	Down 1.41%
China Biologic Products (01177)	5.3	Down 1.85%